Talaris lands $100 mln Series A
Boston and Louisville-based Talaris Therapeutics Inc, a biotechnology company, has secured $100 million in Series A financing. Blackstone Life Sciences led the round with participation from Longitude Capital and Qiming Venture Partners USA.
18 April 2019•1 min read
